G R Kinghorn

3.7k total citations
141 papers, 2.4k citations indexed

About

G R Kinghorn is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, G R Kinghorn has authored 141 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Epidemiology, 53 papers in Microbiology and 27 papers in Infectious Diseases. Recurrent topics in G R Kinghorn's work include Reproductive tract infections research (52 papers), Herpesvirus Infections and Treatments (41 papers) and Syphilis Diagnosis and Treatment (23 papers). G R Kinghorn is often cited by papers focused on Reproductive tract infections research (52 papers), Herpesvirus Infections and Treatments (41 papers) and Syphilis Diagnosis and Treatment (23 papers). G R Kinghorn collaborates with scholars based in United Kingdom, United States and Canada. G R Kinghorn's co-authors include B. I. Duerden, P D Woolley, Gill Bell, Charles Lacey, B M Jones, I Geary, M. G. McEntegart, Michael Waugh, Ward Jw and Jonathan Ross and has published in prestigious journals such as The Lancet, PLoS ONE and Scientific Reports.

In The Last Decade

G R Kinghorn

138 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G R Kinghorn United Kingdom 27 1.3k 817 503 386 358 141 2.4k
K. K. Holmes United States 21 630 0.5× 728 0.9× 427 0.8× 425 1.1× 170 0.5× 39 1.6k
Akbar Zaidi United States 28 787 0.6× 1.1k 1.4× 599 1.2× 651 1.7× 186 0.5× 57 2.3k
W I van der Meijden Netherlands 26 836 0.6× 696 0.9× 305 0.6× 234 0.6× 441 1.2× 70 1.6k
Sumner E. Thompson United States 20 1.7k 1.2× 1.2k 1.4× 829 1.6× 218 0.6× 241 0.7× 34 2.8k
Glenda Fehler Australia 25 951 0.7× 1.1k 1.4× 417 0.8× 479 1.2× 263 0.7× 62 1.9k
J.O. Ndinya‐Achola Kenya 25 962 0.7× 1.3k 1.6× 860 1.7× 687 1.8× 184 0.5× 50 2.5k
Bertille de Barbeyrac France 32 1.5k 1.1× 2.1k 2.6× 381 0.8× 225 0.6× 516 1.4× 135 3.1k
Hannelore M Götz Netherlands 28 1.2k 0.9× 1.4k 1.7× 724 1.4× 771 2.0× 309 0.9× 138 2.6k
Emily J. Erbelding United States 29 1.1k 0.8× 1.0k 1.2× 810 1.6× 707 1.8× 133 0.4× 70 2.6k
Lorna K. Rabe United States 28 1.3k 0.9× 1.7k 2.1× 510 1.0× 309 0.8× 133 0.4× 57 2.6k

Countries citing papers authored by G R Kinghorn

Since Specialization
Citations

This map shows the geographic impact of G R Kinghorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G R Kinghorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G R Kinghorn more than expected).

Fields of papers citing papers by G R Kinghorn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G R Kinghorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G R Kinghorn. The network helps show where G R Kinghorn may publish in the future.

Co-authorship network of co-authors of G R Kinghorn

This figure shows the co-authorship network connecting the top 25 collaborators of G R Kinghorn. A scholar is included among the top collaborators of G R Kinghorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G R Kinghorn. G R Kinghorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Heery, Graham P., Carolyn A. Luscombe, G R Kinghorn, et al.. (2022). Astodrimer sodium antiviral nasal spray for reducing respiratory infections is safe and well tolerated in a randomized controlled trial. Scientific Reports. 12(1). 10210–10210. 12 indexed citations
3.
Schwebke, Jane R., Arthur Waldbaum, Kathy Agnew, et al.. (2021). A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis. European Journal of Obstetrics & Gynecology and Reproductive Biology X. 10. 100121–100121. 20 indexed citations
4.
Waldbaum, Arthur, Jane R. Schwebke, Jeremy Ra Paull, et al.. (2020). A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose‑ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis. PLoS ONE. 15(5). e0232394–e0232394. 18 indexed citations
5.
Chavoustie, Steven, Arthur Waldbaum, Gilbert Donders, et al.. (2019). Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% Gel for the treatment of bacterial vaginosis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 245. 13–18. 24 indexed citations
6.
Kinghorn, G R. (2015). Regionalism and Contemporary Artists in Maine: Opportunities and Challenges. Maine policy review. 24(1). 1 indexed citations
7.
Goyder, Elizabeth, et al.. (2014). Social and psychosocial factors associated with high-risk sexual behaviour among university students in the United Kingdom: a web-survey. International Journal of STD & AIDS. 26(6). 369–378. 15 indexed citations
8.
Woodhall, Sarah C, Mark Jit, Kate Soldan, et al.. (2011). The impact of genital warts: loss of quality of life and cost of treatment in eight sexual health clinics in the UK. Sexually Transmitted Infections. 87(6). 458–463. 77 indexed citations
9.
Czoski‐Murray, Carolyn, Jonathan Karnon, Richard A. Jones, Kevin Smith, & G R Kinghorn. (2010). Cost-effectiveness of screening high-risk HIV-positive men who have sex with men (MSM) and HIV-positive women for anal cancer.. Health Technology Assessment. 14(53). iii–iv, ix. 41 indexed citations
10.
Lee, Vincent & G R Kinghorn. (2008). Syphilis: an update. Clinical Medicine. 8(3). 330–333. 14 indexed citations
11.
Mandalia, Sundhiya, M Youle, Ray P. Brettle, et al.. (2008). Treatment Outcome and Cost-Effectiveness of Different Highly Active Antiretroviral Therapy Regimens in the Uk (1996–2002). International Journal of STD & AIDS. 19(5). 297–304. 22 indexed citations
12.
Robinson, Angela & G R Kinghorn. (2005). Sexual health – authors' reply. International Journal of STD & AIDS. 16(4). 328–328. 1 indexed citations
13.
Patel, R, Simon Barton, David Brown, et al.. (2001). European guideline for the management of genital herpes. International Journal of STD & AIDS. 12(2_suppl). 34–39. 23 indexed citations
14.
Kinghorn, G R. (2001). Passion, stigma, and STI. Sexually Transmitted Infections. 77(5). 370–375. 17 indexed citations
15.
Ward, Helen, C A Ison, Sophie Day, et al.. (2000). A prospective social and molecular investigation of gonococcal transmission. The Lancet. 356(9244). 1812–1817. 39 indexed citations
16.
Beck, Eduard J., Sundhiya Mandalia, Ian Williams, et al.. (1999). Decreased morbidity and use of hospital services in English HIV-infected individuals with increased uptake of anti-retroviral therapy 1996-1997. AIDS. 13(15). 2157–2164. 42 indexed citations
17.
Barton, Simon, David Brown, Frances M. Cowan, et al.. (1999). National guideline for the management of genital herpes. UCL Discovery (University College London). 17 indexed citations
18.
Jennings, R., et al.. (1998). Herpesvirus Vaccines. BioDrugs. 10(4). 257–264. 7 indexed citations
19.
20.
Kinghorn, G R, et al.. (1983). Oropharyngeal Haemophilus ducreyi infection.. BMJ. 287(6393). 650–650. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. K. Holmes Breakdown of academic impact, for papers by Akbar Zaidi Breakdown of academic impact, for papers by W I van der Meijden Breakdown of academic impact, for papers by Sumner E. Thompson Breakdown of academic impact, for papers by Glenda Fehler Breakdown of academic impact, for papers by J.O. Ndinya‐Achola Breakdown of academic impact, for papers by Bertille de Barbeyrac Breakdown of academic impact, for papers by Hannelore M Götz Breakdown of academic impact, for papers by Emily J. Erbelding Breakdown of academic impact, for papers by Lorna K. Rabe
Rankless by CCL
2026